skip to main content

S. 141: End Taxpayer Subsidies for Drug Ads Act

We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Jan 28, 2021.

End Taxpayer Subsidies for Drug Ads Act

This bill prohibits a tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs.

Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is in regard to the drug product and primarily targeted to the general public.